Comparison in long-term curative effect of Firebird2TM drug eluting stent and Excel drug eluting stent in treatment of coronary heart disease
NING Shi-feng
ZHANG Xiao-zhong
Abstract：Objective To observe comparatively the long-term curative effect of Firebird2TM drug eluting stent (DES) and Excel drug eluting stent (DES) in treatment of coronary heart disease (CHD).Methods CHD patients (n=97) were chosen and divided into Firebird2TM DES group (n=52) and Excel DES group (n=45). The patients were followed up from Dec. 15, 2014 to Dec. 25, 2014 (average follow-up month=35.95±15.99). The outcome variable included major adverse cardiovascular events (MACE, all-cause mortality, lethal myocardial infarction, target vessel revascularization) and secondary end-point events (NYHA).Results The average aged of chosen patients was 69.16 and percentage of male patients was 59.78%. The difference in baseline data, admission diagnosis, diameter and length of stent, coronary artery lesion and laboratory examinations before stenting had no statistical significance between 2 groups (P>0.05). After follow-up, there was 1 case with lethal myocardial infarction and 1 case with target vessel revascularization and there were 3 cases with all-cause mortality in Firebird2TM DES group, and there were 5 cases with lethal myocardial infarction, 3 cases with target vessel revascularization and 5 cases with all-cause mortality in Excel DES group. The difference in MACE incidence had no statistical significance between 2 groups (P>0.05).Conclusion The curative effect of Excel DES is not better than that of Firebird2TM DES in the long-term treatment of CHD.
Keywords：Coronary heart diseaseDrug eluting stentMajor adverse cardiovascular events
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 91-93 )